An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Why Walking Isn’t Enough When It Comes to Exercise
Walking is often thought of as a mere mode
Can You Eat Cicadas? Yes, and Here’s How to Catch, Clean, and Cook Them
Get ready to see cicadas everywhere.